Fostering Canadian drug research and development for neglected tropical diseases
نویسندگان
چکیده
Patricia Gabriel, MD, is a family medicine resident at St. Paul’s Hospital, Vancouver, BC, Canada. Rebecca Goulding, PhD, is a postdoctoral fellow at the ISIS Research Centre, Sauder School of Business, University of British Columbia, Vancouver. Cecily Morgan-Jonker, BSc, is a medical student at the University of British Columbia. Shannon Turvey, MSc, is a medical student at the University of British Columbia. Jason Nickerson, MA, RRT, is a PhD candidate at the Centre for Global Health, Institute of Population Health, at the University of Ottawa, Ottawa, Ont.
منابع مشابه
First Universities Allied for Essential Medicines (UAEM) Neglected Diseases and Innovation Symposium
Universities Allied for Essential Medicines organized its first Neglected Diseases and Innovation Symposium to address expanding roles of public sector research institutions in innovation in research and development of biomedical technologies for treatment of diseases, particularly neglected tropical diseases. Universities and other public research institutions are increasingly integrated into ...
متن کاملDrug development for neglected diseases: a deficient market and a public-health policy failure.
There is a lack of effective, safe, and affordable pharmaceuticals to control infectious diseases that cause high mortality and morbidity among poor people in the developing world. We analysed outcomes of pharmaceutical research and development over the past 25 years, and reviewed current public and private initiatives aimed at correcting the imbalance in research and development that leaves di...
متن کاملThe drug and vaccine landscape for neglected diseases (2000-11): a systematic assessment.
BACKGROUND In 1975-99, only 1·1% of new therapeutic products had been developed for neglected diseases. Since then, several public and private initiatives have attempted to mitigate this imbalance. We analysed the research and development pipeline of drugs and vaccines for neglected diseases from 2000 to 2011. METHODS We searched databases of drug regulatory authorities, WHO, and clinical tri...
متن کاملOpen-source approaches for the repurposing of existing or failed candidate drugs: learning from and applying the lessons across diseases
Repurposing has the objective of targeting existing drugs and failed, abandoned, or yet-to-be-pursued clinical candidates to new disease areas. The open-source model permits for the sharing of data, resources, compounds, clinical molecules, small libraries, and screening platforms to cost-effectively advance old drugs and/or candidates into clinical re-development. Clearly, at the core of drug-...
متن کاملNO LONGER NEGLECTED Tackling Sierra Leone’s neglected tropical diseases
developmentprogress.org This and other Development Progress materials are available at developmentprogress.org Development Progress is an ODI project that aims to measure, understand and communicate where and how progress has been made in development. ODI is the UK’s leading independent think tank on international development and humanitarian issues. Further ODI materials are available at odi.o...
متن کامل